Amarin Corp Plc (AMRN)

[jessellivermore]

card...

Quote..."Pharma dude explained it yesterday

Once a script reaches pharmacy, Vascepa script gets converted to generic.

Brand name rarely prescribed."

Pharma dud is wrong...Not going happen in this very special situation..Generics can only prescribe for the "Marine" indication. They have no FDA approval for the R-I CVD events label..If they prescribe for the MARINE label with the intent to get R-I via way of "Off Label" then they are infringing on Amarin's patents.

This means the generics are in the same situation Amarin was without the CVD Label expansion...and even if the generics try the off label end run...The drug plans will charge their patients "Marine" label prices which in this case are not the cheapest alternative. Tiers determine the out of pocket expenses for patients and tiers are determined by the price of the drug and not simply awarded on the basis of being a generic..In most situations the Generic price is the lowest so it receives the lowest Tier...But in the case of the Marine label Generic Vascepa will not be the cheapest alternative..Lovaza and generic lovaza have the same label as Generic Vascepa and are lower priced...So generic Vascepa will be Tier 4 and could cost patients up to $350/ month...Generic Vascepa expressly can not be prescribed for the R-I label by the federal court ruling...So Generic Vascepa will be Tier four since Lovaza and Generic Lovaza has the same label and will be cheaper than Generic Vascepa...

":>) JL